Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1786.05
-40.05 (-2.19%)
< Home < Back

Sun Pharma subsidiary gets USFDA nod for anti-hypertension drug

Date: 19-11-2009

Drug firm Sun Pharmaceutical Industries subsidiary has received US Drug regulator USFDA approval for anti-hypertension drug yesterday. The anti hyper tension drug is Nicardipine Hydrochloride injections, that will be available in the strength of 25 mg/10ml. The injections are used for short-term treatment of hypertension when oral therapy is not feasible.

crackcrack